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ABSTRACT 
Background:  Trigeminal neuralgia is a syndrome typicallyconsidered by involuntarypain in the distribution of 
Fifth nerve that are activated by non-noxious stimuli. Medical Treatment with anticonvulsant remained the 1st 
line of treatment.3 If the disease becomes non responsive, there are numerous surgical options like MVD or 
minimally invasive percutaneous lesioning of the trigeminal nerve, such as glycerol rhizolysis, Balloon 
Compression, Radiofrequency Rhizotomy. 
Objective:  To determine efficacy of percutaneous Radiofrequency Rhizotomy for trigeminal neuralgia in terms of 
early pain relief in a tertiary care hospital. 
Materials and Methods:  62 patients with refractory trigeminal neuralgia or lancinating, recurrent episodes of 
pain in the distribution ofOphthalmic (V1) andMandibular (V3) branches of the trigeminal nerve, not responsive 
to 6 months of conservative treatment were included. 
Result:  In our study population, 62 included patients were had mean age 56.08 ± 7.39 years. 44 patients (71%) 
were male. Our treatment was effective in 58 patients (93.5%), while there was recurrence among 4 (6.5%) only. 
Conclusion:  It is concluded that the efficacy of percutaneous Radiofrequency Rhizotomy for trigeminal neuralgia 
in terms of complete relief of pain with intact sensations in treated branch region is excellent (93.5%). 
Keywords:  Percutaneous Radiofrequency Rhizotomy, Trigeminal neuralgia efficacy, Mandibular Branch V3, 
Ophthalmic division of fifth nerve. 
 
INTRODUCTION 
TGNis a syndrome considered by involuntary facial 
pain. It is one of the most painful and debilitating 
craniofacial pain disorders.1 The occurrence of 
trigeminal neuralgia is estimated at 12.6 per 100,000 
person-years.Women are more frequently affected 
than men, in a ratio about 2.5:1.2 Refractory trigeminal 
neuralgia is a lifelong disease affecting quality of life 
adversely.Though all surgical procedures allow pain 
relief in trigeminal neuralgia, from acost-effective 
point of view, percutaneous techniques of 
radiofrequency Rhizotomy are more cost-effective.8 
 Radiofrequency Rhizotomy is currently in use in 
our setup as it costs a patient minimal and 
complication rate is low as compared with other 
surgical interventions, but there has been no 
systematic observation for its efficacy locally. 
 Trends for intervention are changing all over the 
world.9 The recent advances and evidences are using 
CT guided approach5,7 which is not possible in our 
circumstances. So, current study will help audit the 
current practices in our hospitals against the standard 
outcome achieved elsewhere as there is no local data 
available to determine the outcome of Radiofrequency 
Rhizotomy in terms of early pain relief. If the disease 
becomes medically refractory, there are numerous 
surgical options like MVD or minimally invasive 
percutaneous lesioning of the trigeminal nerve, such as 
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Balloon Compression Radiofrequency Rhizotomy, 
glycerol rhizolysis.3-5 
 
MATERIALS AND METHODS 
Study Design 
Prospective study. 
 
Inclusion Criteria 
Sixty two patients with refractory trigeminal neuralgia 
or lancinating, recurrent episodes of pain in the 
distribution of Ophthalmic (V1) and Mandibular (V3) 
branches of the trigeminal nerve, not responsive to 6 
months of conservative treatment were included after 
taking written consent from the patient and after the 
approval from the ethical committee of the hospital. 
Study was completed in one year i.e., from March 
2015 to Feb 2016. 
 
Exclusion Criteria 
Recurrent cases. 
 
Data Collection 
Data was entered in specially designed performa. 
 
Data Analysis 
By SPSS Version 20. 
 
RESULTS 
Age Incidence 
In our study population, 62 patients were included 
with a mean age of 56.08 ± 7.398 ranged from 43 to 
67 years .44 patients (71%) in our study population, 
were under 60 years of age whereas, 18 patients (29%) 
were either 60 years or more in age (Table 1). 
 
Table 1: Frequency Distribution of sampled 
population by Age Groups. 
 
 Frequency Percent 
Valid 
Less than 60 Years 44   71.0 
60 Years and more 18   29.0 
Total 62 100.0 
 
Gender Distribution 
Forty four patients (71%) were male and remaining 18 
(29%) were female. 
 
Table 2: Frequency Distribution of sampled populat-
ion by Time since Diagnosis > 1 Year. 
 
 Frequency Percent 
Valid 
Less than 5 Years 33   53.2 
5 Years and more 29   46.8 
Total 62 100.0 
 
Clinical Presentation 
Thirty three patients (53.2%) of study population has 
been diagnosed in less than 5 years whereas in 29 
patients (46.8%), it was more than 5 years (Table 2). 
Branch V3 (mandibular) was involved in 50 patients 
(80.6%) 12 (19.4%) patients had involvement of 
ophthalmic division of trigeminal nerve (Table 3). 
 
Table 3: Frequency Distribution of sampled 
population by Branch Involved. 
 
 Frequency Percent 
Valid 
V3 50   80.6 
V1 12   19.4 
Total 62 100.0 
 
 Our treatment was effective in 58 patients (93.5%) 
while, there was a recurrence among 4 (6.5%) only 
(Table 4). When we cross tabulated age group with 
efficacy, 41 patients with positive efficacy were less 
than 60 years of age and remaining 17 with positive 
were either 60 years of age or more. When we applied 
 
Table 4: Frequency Distribution of sampled 
population by Efficacy 
 
 Frequency Percent 
Valid 
No   4     6.5 
Yes 58   93.5 
Total 62 100.0 
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fisher exact test results were non-significant (p = 
0.854) (Table 5). 
 When time of diagnosis was cross tabulated with 
efficacy, using fisher’s exact test, results were non-
significant (p = 0.116) (Table 6). 
 
DISCUSSION 
Although all surgical procedures allow pain relief in 
trigeminal neuralgia, from a cost-effective point of 
view, percutaneous techniques of radiofrequency 
Rhizotomyare more cost-effective.8 Radiofrequency
 
Table 5: Cross tabulation between Age groups & 
Efficacy. 
 
 
Efficacy 
Total 
No Yes 
Age 
groups 
Less than 60 Years 3 41 44 
60 Years and more 1 17 18 
Total 4 58 62 
Using Fischer exact test = 0.854 (non-significant) 
 
Rhizotomy is currently in use in our setup 
as it costs a patient minimal and 
complication rate is low as compared with 
other surgical procedure but there has been 
no systematic observation for its efficacy 
locally. In our study, our treatment was 
effective in 58 patients (93.5%) while, 
there was a recurrence among 4 (6.5%) 
only in terms of complete relief of pain 
with intact sensations in treated branch 
region. 
 In a descriptive case series, the 
surgical result of CT-guided trigeminal 
Rhizotomycame out better in 63 of the 79 
(80%) patients with more than 90% (95% 
 
Table 6: Cross tabulation between Time since Diagnosis > 1 
Year & Efficacy. 
 
 
Efficacy 
Total 
No Yes 
Time since 
Diagnosis > 1 Year 
Less than 5 Years 4 29 33 
5 Years and more 0 29 29 
Total 4 58 62 
Using Fisher's Exact Test = 0.116 
 
CI 87.5-93.7%) pain relief.6 While, another review 
study, it has been concluded that radiofrequency 
Rhizotomy allows for somatotropic nerve mapping, 
selective division lesioning, and provides pain relief in 
up to 97% of patients (needle not mentioned).7 Our 
results matched with CT guided Rhizotomy study 
conducted in Department of Neurosurgery, Chang 
Gung Memorial Hospital, Taiwan 2010, which 
mentioned that the surgical result of CT-guided 
trigeminal Rhizotomy using straight needle came out 
good in 63 of the 79 (80%) patients with more than 
90% pain relief with an incredible outcome in pain 
relief.6 
 Our study results are comparable with another 
study related to the review of percutaneous treatments 
for trigeminal Neuralgia, which concluded that 
radiofrequency Rhizotomy allows for somatotropic 
nerve mapping, selective division lesioning, and 
provides pain relief in up to 97% of patients RFR 
provide effective pain relief in most of the patients.7 
The difference in results may be secondary to 
inclusion of all patients of trigeminal neuralgia 
(maxillary division also) as the needle used was not 
mentioned.7There was no effect of age, gender of 
patient, diabetes and time elapsed since diagnosis on 
efficacy in sampled population. 
 
CONCLUSION 
It is concluded that the efficacy of percutaneous 
radiofrequency Rhizotomy for trigeminal neuralgia in 
terms of complete relief of pain with intact sensations 
in treated branch region is excellent at current sample 
size. As in our study, 93.5% patients showed efficacy 
in terms complete relief of pain with intact sensations 
in treated branch region. There was no effect of age, 
gender of patient, diabetes and time elapsed since 
diagnosis on efficacy in sampled population. 
 
Limitation 
The current study included non-representative sample 
and non-probability sampling technique.It is a single 
centered study and a randomized controlled trial is 
needed for more comprehensive results. 
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